Implant Sciences Corporation (OTCQB: IMSC) (PINKSHEETS: IMSC), a high technology supplier of systems and sensors for homeland security markets, today announced it has signed agreements with key end-user sites in the United States, Asia, and South America to test its newly launched Quantum Sniffer(TM) QS-B220 bench-top explosives and narcotics trace detector. The systems will be deployed in actual operational environments in both airport security and air cargo screening facilities.
"We are pleased with the enthusiastic response the QS-B220 is receiving from the user community. Containing no radioactive materials, Implant Sciences' products screen passengers and cargo without health or environmental risks," stated Implant Sciences CEO, Glenn D. Bolduc.
Todd Silvestri, Vice President of Product Development added, "The QS-B220 has been designed to meet or exceed all TSA requirements. With automatic calibration, high throughput, and low maintenance needs, the system is ideally suited for security screening applications."
Related Research on ASDReports.com: